Resverlogix

0 followers


Resverlogix is a biopharmaceutical company, focused on the development of therapeutics in cardiovascular diseases and Alzheimer’s disease.

Headquarters

Calgary, Canada

Employees

11-50

Links

Org chart

Donald J. McCaffrey
President & CEO

Donald J. McCaffrey

Collapse
Ewelina Kulikowski
Chief Scientific Officer
Michael Sweeney
SVP, Clinical Development
Henrik C. Hansen
VP, Intellectual Property